Latest News
Aerogen are offering a new Continuing Respiratory Care Education (CRCE) module: Aerosols & Children. This is a one hour module and is accredited by the American Association of Respiratory Care (AARC). Click here to register.
CEO of Aerogen, John Power is the Connaught winner of International Business Award in the Ulster Bank Business Achievers Award 2009.
Aerogen has completed a management buyout (MBO) from its US parent, Nektar Therapeutics for an undisclosed amount.
“This deal empowers Aerogen to grow our business and expand our product offerings,” commented John Power, CEO, Aerogen. Aerogen has advanced negotiations in several exciting areas and plans to announce new partnerships with a number of US and European market leaders in both the medical field and commercial products area in the near future.
“This deal empowers Aerogen to grow our business and expand our product offerings,” commented John Power, CEO, Aerogen. Aerogen has advanced negotiations in several exciting areas and plans to announce new partnerships with a number of US and European market leaders in both the medical field and commercial products area in the near future.
The Aeroneb® Solo represents a new dimension in acute care nebulization and is the first single patient use, high efficiency nebulizer available to care givers.
